Sizes of these terms reflect their relevance to your search.
The CLIP1-LTK fusion drives advanced non-small cell lung cancer (NSCLC) and represents a therapeutic target. ©2022 American Association for Cancer Research.
Citation
The CLIP1-LTK Fusion Is an Oncogenic Driver of NSCLC. Cancer discovery. 2022 Feb;12(2):286
PMID: 34893497
View Full Text
